Fibrillin-1 regulates the bioavailability of TGFβ1

Citations Over TimeTop 1% of 2007 papers

Abstract

We have discovered that fibrillin-1, which forms extracellular microfibrils, can regulate the bioavailability of transforming growth factor (TGF) beta1, a powerful cytokine that modulates cell survival and phenotype. Altered TGFbeta signaling is a major contributor to the pathology of Marfan syndrome (MFS) and related diseases. In the presence of cell layer extracellular matrix, a fibrillin-1 sequence encoded by exons 44-49 releases endogenous TGFbeta1, thereby stimulating TGFbeta receptor-mediated Smad2 signaling. This altered TGFbeta1 bioavailability does not require intact cells, proteolysis, or the altered expression of TGFbeta1 or its receptors. Mass spectrometry revealed that a fibrillin-1 fragment containing the TGFbeta1-releasing sequence specifically associates with full-length fibrillin-1 in cell layers. Solid-phase and BIAcore binding studies showed that this fragment interacts strongly and specifically with N-terminal fibrillin-1, thereby inhibiting the association of C-terminal latent TGFbeta-binding protein 1 (a component of the large latent complex [LLC]) with N-terminal fibrillin-1. By releasing LLC from microfibrils, the fibrillin-1 sequence encoded by exons 44-49 can contribute to MFS and related diseases.

Related Papers

• → LTBP1 promotes fibrillin incorporation into the extracellular matrix(2022)18 cited
• → Effect of Transforming Growth Factor-beta (TGF-β) on Mammary Development(2003)11 cited
• → Short-or long-term effects of a low-protein diet on fibronectin and transforming growth factor-β synthesis in Adriamycin-induced nephropathy(アドリアマイシン腎症における短期および長期の低蛋白食投与の効果 -フィブロネクチンおよびtransforming growth factor(TGF)-β産生について)(1997)
• The Progress in Researches on TGF-β and its Receptor in Marfan Syndrome(2008)
• → Extracellular Matrix (ECM) Proteins in Airway and in COPD Mice: Regional Expression Difference and Potential Mechanism Mediated by Transforming Growth Factor-β1 (TGF-β1)(2019)